تقرير تحليل حجم سوق منتجات المعالجة المثلية في المكسيك، وحصتها السوقية، واتجاهاتها - نظرة عامة على الصناعة وتوقعاتها حتى عام 2032

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE MEXICO HOMEOPATHY PRODUCTS MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 YEARS CONSIDERED FOR THE STUDY

2.3 DBMR TRIPOD DATA VALIDATION MODEL

2.4 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.5 MEXICO HOMEOPATHY PRODUCTS MARKET: MULTIVARIATE MODELLING

2.6 DBMR MARKET POSITION GRID

2.7 MARKET END USER COVERAGE GRID

2.8 VENDOR SHARE ANALYSIS

2.9 SECONDARY SOURCES

2.1 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTAL ANALYSIS

4.2 PORTERS FIVE FORCES ANALYSIS

4.3 CUSTOMER BEHAVIOR ANALYSIS: MEXICO HOMEOPATHY PRODUCTS MARKET

4.4 EPIDEMIOLOGY: MEXICO HOMEOPATHY PRODUCTS MARKET

4.5 HOMEOPATHY ADOPTION IN MEXICO

4.6 DRUG TREATMENT RATE BY MATURED MARKETS: MEXICO HOMEOPATHY PRODUCTS MARKET

4.7 KEY PRICING STRATEGIES: MEXICO HOMEOPATHY PRODUCTS MARKET

4.8 TOP 10 BEST-SELLING HOMEOPATHY PRODUCTS IN THE MEXICO MARKET

5 MEXICO HOMEOPATHY PRODUCTS MARKET, REGULATORY FRAMEWORK

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING CONSUMER AWARENESS OF NATURAL HEALTH SOLUTIONS

6.1.2 RISING PREVALENCE OF CHRONIC DISEASES

6.1.3 AFFORDABILITY DRIVES GROWING ADOPTION OF HOMEOPATHIC REMEDIES AS A HEALTHCARE SOLUTION

6.2 RESTRAINTS

6.2.1 LACK OF SCIENTIFIC EVIDENCE

6.2.2 INEFFECTIVENESS IN TREATING LIFE-THREATENING INFECTIONS

6.3 OPPORTUNITIES

6.3.1 ADVOCACY BY GOVERNMENT FOR HOMEOPATHY

6.3.2 AVAILABILITY OF HOMEOPATHY MEDICINES IN E-COMMERCE

6.3.3 UTILIZING HOMEOPATHY AS AN ADJUNCT TREATMENT

6.4 CHALLENGES

6.4.1 DELAYED THERAPEUTIC RESPONSE OF HOMEOPATHIC MEDICINES

6.4.2 REGULATORY AND LEGAL ISSUES

7 MEXICO HOMEOPATHY PRODUCTS MARKET, BY PRODUCT TYPE

7.1 OVERVIEW

7.2 DILUTIONS

7.2.1 BY POTENCY

7.2.1.1 HIGH POTENCY

7.2.1.1.1 50M

7.2.1.1.2 CM (CENTESIMAL)

7.2.1.2 MEDIUM POTENCY

7.2.1.2.1 10M

7.2.1.2.2 1M

7.2.1.2.3 200C

7.2.1.2.4 30C

7.2.1.3 LOW POTENCY

7.2.1.3.1 LM (50 MILLESIMAL)

7.2.1.3.2 30X

7.2.1.3.3 12X

7.2.1.3.4 6X

7.2.2 BY SOURCE

7.2.2.1 PLANTS

7.2.2.1.1 HERBS

7.2.2.1.2 FLOWERS

7.2.2.1.3 TREES

7.2.2.2 MINERALS

7.2.2.2.1 NON-METALLIC MINERALS

7.2.2.2.1.1 CALCAREA CARBONICA (CALCIUM CARBONATE)

7.2.2.2.1.2 SILICEA (SILICA)

7.2.2.2.1.3 OTHERS

7.2.2.2.2 METALLIC MINERALS

7.2.2.2.2.1 AURUM METALLICUM (GOLD)

7.2.2.2.2.2 FERRUM METALLICUM (IRON)

7.2.2.2.2.3 OTHERS

7.2.2.3 ANIMALS

7.2.2.3.1 APIS MELLIFICA (HONEYBEE)

7.2.2.3.2 LACHESIS MUTA (BUSHMASTER SNAKE)

7.2.2.3.3 OTHERS

7.3 TABLETS

7.3.1 SUGAR-BASED TABLETS

7.3.2 PILLULES AND PELLETS

7.3.3 LACTOSE-FREE TABLETS

7.3.4 ORALLY DISINTEGRATING TABLETS (ODTS)

7.3.5 OTHERS

7.4 TINCTURE

7.4.1 BY PRODUCT TYPE

7.4.1.1 ARNICA

7.4.1.2 ECHINACEA

7.4.1.3 TURMERIC

7.4.1.4 ELDERBERRY

7.4.1.5 PROPOLIS

7.4.1.6 HYPERICUM PERFORATUM

7.4.1.7 ACONITUM

7.4.1.8 HEPAR SULPHURIS CALCAREUM

7.4.1.9 STAPHYSAGRIA

7.4.1.10 BENZOIN

7.4.1.11 IODINE

7.4.1.12 CANNABIS

7.4.1.13 OTHERS

7.4.2 BY TYPE,

7.4.2.1 ROOTS

7.4.2.2 LEAF

7.4.2.3 FLOWER

7.4.2.4 OTHERS

7.4.3 BY SOURCE

7.4.3.1 PLANTS

7.4.3.1.1 CANNABIS

7.4.3.1.2 CHAMOMILE

7.4.3.1.3 GINGKO

7.4.3.1.4 GINGER

7.4.3.1.5 VALERIAN

7.4.3.1.6 GARLIC

7.4.3.1.7 FEVERFEW

7.4.3.1.8 MILK THISTLE

7.4.3.1.9 GINSENG

7.4.3.1.10 SAW PALMETTO

7.4.3.1.11 OTHERS

7.4.3.2 MINERALS

7.4.3.3 ANIMALS

7.5 OINTMENTS

7.5.1 BY SIZE

7.5.1.1 30 GM

7.5.1.2 60 GM

7.5.1.3 25 GM

7.5.1.4 75 GM

7.5.1.5 OTHERS

7.5.2 BY USAGE

7.5.2.1 TOPICAL PAIN RELIEF

7.5.2.1.1 MUSCLE PAIN

7.5.2.1.2 ARTHRITIS

7.5.2.1.3 JOINT PAIN

7.5.2.1.4 PILES & FISSURES

7.5.2.1.5 INSECT BITES & HIVES

7.5.2.1.6 OTHERS

7.5.2.2 SKIN CONDITIONS

7.5.2.2.1 PSORIASIS

7.5.2.2.2 ECZEMA

7.5.2.2.3 ACNE

7.5.2.2.4 OTHERS

7.5.2.3 SCAR HEALING

7.5.2.4 BURN AND WOUND CARE

7.5.2.5 OTHERS

7.6 BIOCHEMICS

7.6.1 PLANTS

7.6.2 MINERALS

7.6.3 ANIMALS

7.7 OILS

7.7.1 ARNICA OIL

7.7.2 CALENDULA OIL

7.7.3 HYPERICUM OIL

7.7.4 RHUS TOXICODENDRON OIL

7.7.5 BELLADONNA OIL

7.7.6 LAVENDER OIL

7.7.7 CHAMOMILE OIL

7.7.8 MENTHOLATED OIL

7.7.9 EUCALYPTUS OIL

7.7.10 OTHERS

7.8 OTHERS

8 MEXICO HOMEOPATHY PRODUCTS MARKET, BY AGE GROUP

8.1 OVERVIEW

8.2 ADULTS

8.3 GERIATRIC

8.4 PEDIATRIC

9 MEXICO HOMEOPATHY PRODUCTS MARKET, BY GENDER

9.1 OVERVIEW

9.2 MEN

9.3 WOMEN

10 MEXICO HOMEOPATHY PRODUCTS MARKET, BY TREATMENT

10.1 OVERVIEW

10.2 CLASSICAL HOMEOPATHY

10.3 CLINICAL HOMEOPATHY

10.4 COMPLEX HOMEOPATHY

10.5 OTHERS

11 MEXICO HOMEOPATHY PRODUCTS MARKET, BY SOURCE

11.1 OVERVIEW

11.2 PLANTS

11.2.1 CANNABIS

11.2.2 CHAMOMILE

11.2.3 GINGKO

11.2.4 GINGER

11.2.5 VALERIAN

11.2.6 GARLIC

11.2.7 FEVERFEW

11.2.8 MILK THISTLE

11.2.9 GINSENG

11.2.10 SAW PALMETTO

11.2.11 OTHERS

11.3 MINERALS

11.3.1 NON-METALLIC MINERALS

11.3.1.1 CALCAREA CARBONICA (CALCIUM CARBONATE)

11.3.1.2 SILICEA(SILICA)

11.3.1.3 OTHERS

11.3.2 METALLIC MINERALS

11.3.2.1 AURUM METALLICUM(GOLD)

11.3.2.2 FERRUM METALLICUM(IRON)

11.3.2.3 OTHERS

11.4 ANIMALS

11.4.1 APIS MELLIFICA (HONEYBEE)

11.4.2 LACHESIS MUTA (BUSHMASTER SNAKE)

11.4.3 OTHERS

12 MEXICO HOMEOPATHY PRODUCTS MARKET, BY APPLICATION

12.1 OVERVIEW

12.2 ANALGESIC AND ANTIPYRETIC

12.2.1 MUSCLES AND JOINT PAIN

12.2.2 SWELLING AND BRUISING

12.2.3 POST-SURGICAL PAIN

12.2.4 SPRAINS, STRAINS, AND MINOR TRAUMAS

12.2.5 OTHERS

12.3 RESPIRATORY DISEASES

12.3.1 UPPER RESPIRATORY TRACT INFECTIONS (URTIS)

12.3.2 ALLERGIC RHINITIS

12.3.3 ASTHMA

12.3.4 BRONCHITIS

12.3.5 SINUSITIS

12.3.6 COUGHS

12.3.7 OTHERS

12.4 IMMUNOLOGY DISORDERS

12.5 GASTROENTEROLOGY DISORDERS

12.5.1 DIGESTIVE DISCOMFORTS

12.5.2 DYSPEPSIA

12.5.3 BLOATING

12.5.4 CONSTIPATION

12.5.5 DIARRHEA

12.5.6 OTHERS

12.6 NEUROLOGY DISORDERS

12.6.1 MIGRAINES AND HEADACHES

12.6.2 NEUROPATHIC PAIN

12.6.3 RESTLESS LEG SYNDROME (RLS)

12.6.4 EPILEPSY

12.6.5 PARKINSON’S DISEASE

12.6.6 OTHERS

12.7 DERMATOLOGY DISORDERS

12.7.1 MINOR SKIN IRRITATIONS

12.7.2 INSECT BITES

12.7.3 MINOR SUNBURN

12.7.4 OTHERS

12.8 CNS (CENTRAL NERVOUS SYSTEM)

12.9 MENTAL HEALTH

12.9.1 ANXIETY

12.9.2 STRESS

12.9.3 INSOMNIA

12.9.4 DEPRESSION

12.9.5 OBSESSIVE-COMPULSIVE DISORDER (OCD)

12.9.6 ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)

12.9.7 OTHERS

12.1 HORMONAL DISEASES

12.10.1 PREMENSTRUAL SYNDROME

12.10.2 MENOPAUSAL VASOMOTOR SYMPTOMS

12.10.3 THYROID DISORDERS

12.10.4 OTHERS

12.11 SEXUAL WELLNESS

12.11.1 ERECTILE DYSFUNCTION (ED)

12.11.2 FEMALE SEXUAL DYSFUNCTION

12.11.3 3 INFERTILITY

12.11.4 OTHERS

12.12 OBESITY

12.13 OPHTHALMIC DISEASES

12.13.1 CONJUNCTIVITIS

12.13.2 DRY EYES

12.13.3 RED EYES

12.13.4 EYESTRAIN

12.13.5 UVEITIS

12.13.6 RETINAL DISORDERS

12.13.7 CORNEAL DISEASES

12.13.8 CROSS EYES (STRABISMUS)

12.13.9 NYSTAGMUS

12.13.10 OTHERS

12.14 OTHERS

13 MEXICO HOMEOPATHY PRODUCTS MARKET, BY MODE OF PURCHASE

13.1 OVERVIEW

13.2 OVER THE COUNTER (OTC)

13.3 PRESCRIPTION-BASED

14 MEXICO HOMEOPATHY PRODUCTS MARKET, BY ROUTE OF ADMINISTRATION

14.1 OVERVIEW

14.2 ORAL PRODUCTS

14.2.1 BY SOURCE

14.2.1.1 PLANTS

14.2.1.1.1 CANNABIS

14.2.1.1.2 CHAMOMILE

14.2.1.1.3 GINGKO

14.2.1.1.4 GINGER

14.2.1.1.5 VALERIAN

14.2.1.1.6 GARLIC

14.2.1.1.7 FEVERFEW

14.2.1.1.8 MILK THISTLE

14.2.1.1.9 GINSENG

14.2.1.1.10 SAW PALMETTO

14.2.1.1.11 OTHERS

14.2.1.2 MINERALS

14.2.1.2.1 NON-METALLIC MINERALS

14.2.1.2.1.1 CALCAREA CARBONICA (CALCIUM CARBONATE)

14.2.1.2.1.2 SILICEA(SILICA)

14.2.1.2.1.3 OTHERS

14.2.1.2.2 METALLIC MINERALS

14.2.1.2.2.1 AURUM METALLICUM (GOLD)

14.2.1.2.2.2 FERRUM METALLICUM (IRON)

14.2.1.2.2.3 OTHERS

14.2.1.3 ANIMALS

14.2.1.3.1 APIS MELLIFICA (HONEYBEE)

14.2.1.3.2 LACHESIS MUTA (BUSHMASTER SNAKE)

14.2.1.3.3 OTHERS

14.3 TOPICAL PRODUCTS

14.3.1 BY SOURCE

14.3.1.1 PLANTS

14.3.1.1.1 CANNABIS

14.3.1.1.2 CHAMOMILE

14.3.1.1.3 GINGKO

14.3.1.1.4 GINGER

14.3.1.1.5 VALERIAN

14.3.1.1.6 GARLIC

14.3.1.1.7 FEVERFEW

14.3.1.1.8 MILK THISTLE

14.3.1.1.9 GINSENG

14.3.1.1.10 SAW PALMETTO

14.3.1.1.11 OTHERS

14.3.1.2 MINERALS

14.3.1.2.1 NON-METALLIC MINERALS

14.3.1.2.1.1 CALCAREA CARBONICA (CALCIUM CARBONATE)

14.3.1.2.1.2 SILICEA (SILICA)

14.3.1.2.1.3 OTHERS

14.3.1.2.2 METALLIC MINERALS

14.3.1.2.2.1 AURUM METALLICUM (GOLD)

14.3.1.2.2.2 FERRUM METALLICUM (IRON)

14.3.1.2.2.3 OTHERS

14.3.1.3 ANIMALS

14.3.1.3.1 APIS MELLIFICA (HONEYBEE)

14.3.1.3.2 LACHESIS MUTA (BUSHMASTER SNAKE)

14.3.1.3.3 OTHERS

14.4 OTHERS

15 MEXICO HOMEOPATHY PRODUCTS MARKET, BY END USER

15.1 OVERVIEW

15.2 HOMEOPATHY CENTERS

15.3 CLINICS

15.4 HOSPITAL

15.4.1 PUBLIC HOSPITALS

15.4.2 PRIVATE HOSPITALS

15.5 HOMECARE

15.6 OTHERS

16 MEXICO HOMEOPATHY PRODUCTS MARKET, BY DISTRIBUTION CHANNEL

16.1 OVERVIEW

16.2 RETAIL SALES

16.2.1 RETAIL PHARMACY

16.2.2 ONLINE PHARMACY

16.2.3 HOSPITAL PHARMACY

16.3 DIRECT TENDER

16.4 OTHERS

17 MEXICO HOMEOPATHY PRODUCTS MARKET: COMPANY LANDSCAPE

17.1 COMPANY SHARE ANALYSIS: MEXICO

18 SWOT ANALYSIS

19 COMPANY PROFILES

19.1 SCHWABE MÉXICO, S.A. DE C.V. (DR. WILLMAR SCHWABE GMBH & CO. KG)

19.1.1 COMPANY SNAPSHOT

19.1.2 PRODUCT PORTFOLIO

19.1.3 RECENT DEVELOPMENTS

19.2 BIOLOGISCHE HEILMITTEL HEEL GMBH

19.2.1 COMPANY SNAPSHOT

19.2.2 PRODUCT PORTFOLIO

19.2.3 RECENT DEVELOPMENT

19.3 NARTEX LABS

19.3.1 COMPANY SNAPSHOT

19.3.2 PRODUCT PORTFOLIO

19.3.3 RECENT DEVELOPMENT

19.4 AF OPERADORA DE NEGOCIOS S.A. DE C.V.

19.4.1 COMPANY SNAPSHOT

19.4.2 PRODUCT PORTFOLIO

19.4.3 RECENT DEVELOPMENT

19.5 NATURAL AND ORGANIC FARMS MÉXICO, S.A. DE C.V.

19.5.1 COMPANY SNAPSHOT

19.5.2 PRODUCT PORTFOLIO

19.5.3 RECENT DEVELOPMENT

19.6 BOTANIC HEALTHCARE.

19.6.1 COMPANY SNAPSHOT

19.6.2 PRODUCT PORTFOLIO

19.6.3 RECENT DEVELOPMENT

19.7 DR. RECKEWEG & CO. GMBH

19.7.1 COMPANY SNAPSHOT

19.7.2 PRODUCT PORTFOLIO

19.7.3 RECENT DEVELOPMENT

19.8 HÄSLER HOMEOPATHIC LABORATORIES

19.8.1 COMPANY SNAPSHOT

19.8.2 PRODUCT PORTFOLIO

19.8.3 RECENT DEVELOPMENT

19.9 SIMILIA

19.9.1 COMPANY SNAPSHOT

19.9.2 PRODUCT PORTFOLIO

19.9.3 RECENT DEVELOPMENT

19.1 SINERGIA FARMACÉUTICA SAPI DE CV (BIOFARMA NATURAL CMD SA DE CV)

19.10.1 COMPANY SNAPSHOT

19.10.2 PRODUCT PORTFOLIO

19.10.3 RECENT DEVELOPMENT

20 QUESTIONNAIRE

21 RELATED REPORTS